Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Thomas

Showing results (111-120 of 483) with videos related to

Pageof 49
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 3, 2002
Peginterferon-alpha-2a (40kD) and ribavirin in patients with chronic hepatitis C: a phase II open-label studyMark Sulkowski, Robert Reindollar, David L Thomas, et al.
American Journal of Physical Anthropology|April 4, 2007
Collagen turnover in the adult femoral mid-shaft: modeled from anthropogenic radiocarbon tracer measurementsRobert E M Hedges, John G Clement, C David L Thomas, et al.
Bone|March 24, 2009
The relation of femoral osteon geometry to age, sex, height and weightHayley M Britz, C David L Thomas, John G Clement, et al.
Journal of Health Care for the Poor and Underserved|November 28, 2023
Incarceration, Inequality, and Hepatitis C Treatment: The Story of Two Southern StatesAshley Wennerstrom, Sean Manogue, Hannah Hardeo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2004
Changes in hepatitis B virus DNA levels with acute HIV infectionChloe L Thio, Dale M Netski, Jane Myung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug usersIrene Kuo, Daniel W Mudrick, Steffanie A Strathdee, et al.
Transfusion|September 24, 2004
Risk factors for hepatitis C virus infection among blood donors in northern ThailandLakkana Thaikruea, Satawat Thongsawat, Niwat Maneekarn, et al.
Hepatology (Baltimore, Md.)|January 31, 2004
High prevalence of occult hepatitis B in Baltimore injection drug usersMichael Torbenson, Rajesh Kannangai, Jacquie Astemborski, et al.
Radiology|October 19, 2016
Arterial Spin Labeling Perfusion of the Brain: Emerging Clinical ApplicationsSven Haller, Greg Zaharchuk, David L Thomas, et al.
Hepatology (Baltimore, Md.)|January 12, 2002
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infectionsMark S Sulkowski, David L Thomas, Shruti H Mehta, et al.
Pageof 49

Showing results (111-120 of 483) with videos related to

Sort By:
Pageof 49
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 3, 2002
Peginterferon-alpha-2a (40kD) and ribavirin in patients with chronic hepatitis C: a phase II open-label studyMark Sulkowski, Robert Reindollar, David L Thomas, et al.
American Journal of Physical Anthropology|April 4, 2007
Collagen turnover in the adult femoral mid-shaft: modeled from anthropogenic radiocarbon tracer measurementsRobert E M Hedges, John G Clement, C David L Thomas, et al.
Bone|March 24, 2009
The relation of femoral osteon geometry to age, sex, height and weightHayley M Britz, C David L Thomas, John G Clement, et al.
Journal of Health Care for the Poor and Underserved|November 28, 2023
Incarceration, Inequality, and Hepatitis C Treatment: The Story of Two Southern StatesAshley Wennerstrom, Sean Manogue, Hannah Hardeo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2004
Changes in hepatitis B virus DNA levels with acute HIV infectionChloe L Thio, Dale M Netski, Jane Myung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug usersIrene Kuo, Daniel W Mudrick, Steffanie A Strathdee, et al.
Transfusion|September 24, 2004
Risk factors for hepatitis C virus infection among blood donors in northern ThailandLakkana Thaikruea, Satawat Thongsawat, Niwat Maneekarn, et al.
Hepatology (Baltimore, Md.)|January 31, 2004
High prevalence of occult hepatitis B in Baltimore injection drug usersMichael Torbenson, Rajesh Kannangai, Jacquie Astemborski, et al.
Radiology|October 19, 2016
Arterial Spin Labeling Perfusion of the Brain: Emerging Clinical ApplicationsSven Haller, Greg Zaharchuk, David L Thomas, et al.
Hepatology (Baltimore, Md.)|January 12, 2002
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infectionsMark S Sulkowski, David L Thomas, Shruti H Mehta, et al.
Pageof 49